financetom
Business
financetom
/
Business
/
Duolingo Insider Sold Shares Worth $1,035,725, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Duolingo Insider Sold Shares Worth $1,035,725, According to a Recent SEC Filing
Nov 19, 2025 2:10 PM

04:37 PM EST, 11/19/2025 (MT Newswires) -- Matthew Skaruppa, Chief Financial Officer, on November 17, 2025, sold 5,858 shares in Duolingo ( DUOL ) for $1,035,725. Following the Form 4 filing with the SEC, Skaruppa has control over a total of 37,487 Class A common shares of the company, with 37,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1562088/000162828025053183/xslF345X05/wk-form4_1763587234.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlas Lithium's Processing Plant Preparing for Shipment to Brazil
Atlas Lithium's Processing Plant Preparing for Shipment to Brazil
Jan 21, 2025
01:07 PM EST, 01/21/2025 (MT Newswires) -- Atlas Lithium ( ATLX ) said Tuesday its lithium processing plant is preparing for shipment from South Africa to Brazil. The shipment would consist of 141 containers and 10 bulk items and would depart via a chartered vessel on Jan. 31, the company said. The company said the shipment is a key milestone...
Aar Insider Sold Shares Worth $354,027, According to a Recent SEC Filing
Aar Insider Sold Shares Worth $354,027, According to a Recent SEC Filing
Jan 21, 2025
01:03 PM EST, 01/21/2025 (MT Newswires) -- John McClain Holmes III, Director, Chairman, President & CEO, on January 17, 2025, sold 5,000 shares in Aar (AIR) for $354,027. Following the Form 4 filing with the SEC, Holmes has control over a total of 341,680 shares of the company, with 341,680 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1750/000112760225001587/xslF345X05/form4.xml Price: 72.64, Change: +2.43,...
Catalyst Pharmaceuticals Sub-Licensee DyDo Pharma Launches Firdapse in Japan for Autoimmune Disorder Treatment
Catalyst Pharmaceuticals Sub-Licensee DyDo Pharma Launches Firdapse in Japan for Autoimmune Disorder Treatment
Jan 21, 2025
01:05 PM EST, 01/21/2025 (MT Newswires) -- Catalyst Pharmaceuticals ( CPRX ) said Tuesday that its sub-licensee, DyDo Pharma, has launched Firdapse, or amifampridine, tablets 10 mg in Japan to treat muscle weakness in patients with Lambert-Eaton myasthenic syndrome, or LEMS, a rare autoimmune disorder. Firdapse is the only treatment approved by the US Food and Drug Administration for LEMS...
Update: Tempus AI Shares Up After AI-Powered Health App Launch
Update: Tempus AI Shares Up After AI-Powered Health App Launch
Jan 21, 2025
01:08 PM EST, 01/21/2025 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.) Tempus AI ( TEM ) shares were up more than 32% in recent trading Tuesday after the company said it launched olivia, an AI-powered app that draws together personal health data and uses AI to provide actionable insights. The company said the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved